Back to Search
IVOR CARO, M.D.
M.D.
Dermatology Physician
NPI: 1811958838Individual
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
160621(MA)
Research & Publications (20)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 5-2003 - a 16-year-old girl with a rash and chest pain.
PMID 12584372·N Engl J Med·2003
5-case
Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis.
PMID 18373710·Br J Dermatol·2008
3-trial
Subcutaneous efalizumab is not effective in the treatment of alopecia areata.
PMID 18280336·J Am Acad Dermatol·2008
3-trial
Study of the lipidic and proteic composition of an industrial filmogenic yeast with applications as a nutritional supplement.
PMID 19090714·J Agric Food Chem·2008
8-other
Safety of efalizumab therapy in patients with moderate to severe psoriasis: an open-label extension of a phase IIIb trial.
PMID 18636790·Drug Saf·2008
2-rct
Phenotypical characteristics of Shiga-like toxin Escherichia coli isolated from sheep dairy products.
PMID 17718842·Lett Appl Microbiol·2007
7-preclinical
Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
PMID 17603880·BMC Public Health·2007
8-other
Occurrence of Shiga toxin-producing Escherichia coli in a Spanish raw ewe's milk cheese.
PMID 17428564·Int J Food Microbiol·2007
7-preclinical
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
PMID 16488338·J Am Acad Dermatol·2006
3-trial
Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial.
PMID 16700803·Int J Dermatol·2006
3-trial
Detection, occurrence, and characterization of Escherichia coli O157:H7 from raw ewe's milk in Spain.
PMID 16629039·J Food Prot·2006
7-preclinical
Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.
PMID 16488337·J Am Acad Dermatol·2006
3-trial
Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluations.
PMID 16235973·Pharmacoeconomics·2005
6-review
Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: review of clinical data. part II.
PMID 16699903·J Cutan Med Surg·2005
4-observational
Incidence of infection during efalizumab therapy for psoriasis: analysis of the clinical trial experience.
PMID 16291408·Clin Ther·2005
4-observational
A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
PMID 16096179·J Dermatolog Treat·2005
4-observational
Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis.
PMID 16021174·J Am Acad Dermatol·2005
3-trial
Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
PMID 15761420·J Am Acad Dermatol·2005
3-trial
Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.
PMID 15655139·Arch Dermatol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 DNA WAY, MAILSTOP 84, GENENTECH
SOUTH SAN FRANCISCO, CA 94080 - Phone
- (650) 225-6370
Quick Facts
- NPI
- 1811958838
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile